10.12.04 Dublin - The global market for MS-drugs will be reshuffled following the FDA's approval of the new MS-drug Tysabri, formerly Antegren, by Irish Elan Corp. and its partner Biogen Idec Inc. Tysabri is the first humanized monoclonal...
more
06.08.04 Dublin - US-Pharmagiant Pfizer Inc. is set to create 200 new jobs with a Euro250 million expansion of its sterile manufacturing facility in Dublin. The new investment will double the number of people employed at the Dún Laoghaire...
more
10.07.04 Dublin/Quebec - Irish IdentiGen Ltd. and Canadian Warnex Inc. - both specialized in detection of genetically modified organisms (GMO) - are to combine their expertise. In late-June the companies signed a licensing agreement to...
more
07.06.04 Dublin - Irish AGI Therapeutics Ltd. in mid-May completed Euro9.5 million-first round financing. The development stage speciality pharmaceutical company will put the money from lead investor ACT Venture Capita and Seroba...
more
08.05.04 Dublin - Irish diagnostics specialist Trinity Biotech plc expands its activities in the US. In mid-April the company acquired the distributor for diagnostic tools, Adaltis US Inc. for $3.5 million in cash. As part of the...
more
